Citation 7947

NAGATSU,A: ZHANG,HL: MIZUKAMI,H: OKUYAMA,H: SAKAKIBARA,J: TOKUDA,H: NISHINO,H:. (2000). TYROSINASE INHIBITORY AND ANTI-TUMOR PROMOTING ACTIVITIES OF COMPOUNDS ISOLATED FROM SAFFLOWER (CARTHAMUS TINCTORIUS L.) AND COTTON (GOSSYPIUM HIRSUTUM L.) OIL CAKES.. 14(3)

Citation Details

Title	TYROSINASE INHIBITORY AND ANTI-TUMOR PROMOTING ACTIVITIES OF COMPOUNDS ISOLATED FROM SAFFLOWER (CARTHAMUS TINCTORIUS L.) AND COTTON (GOSSYPIUM HIRSUTUM L.) OIL CAKES.
Authors	NAGATSU,A: ZHANG,HL: MIZUKAMI,H: OKUYAMA,H: SAKAKIBARA,J: TOKUDA,H: NISHINO,H:
Year	2000
Volume	14
Issue	3

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (3)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KOJIC ACID	STRONG ACTIVITY
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHIZIN	ACTIVE

Carthamus tinctorius (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	SEROTONIN,N-(PARA-COUMAROYL):	None
2	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-(PARA-COUMAROYL):	WEAK ACTIVITY
3	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-(PARA-COUMAROYL):	WEAK ACTIVITY
4	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOSCHAMINE	WEAK ACTIVITY
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MOSCHAMINE	WEAK ACTIVITY
6	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-(PARA-COUMAROYL): 5-O-GLUCOSIDE	EQUIVOCAL
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-(PARA-COUMAROYL): 5-O-GLUCOSIDE	WEAK ACTIVITY
8	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-FERULOYL: 5-O-GLUCOSIDE	WEAK ACTIVITY
9	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,N-FERULOYL: 5-O-GLUCOSIDE	WEAK ACTIVITY
10	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-4''-BIS-(N-PARA-COUMAROYL):	WEAK ACTIVITY
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-4''-BIS-(N-PARA-COUMAROYL):	INACTIVE
12	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-(N-PARA-COUMAROYL)-SEROTONIN-4''-YL]-N-FERULOYL:	WEAK ACTIVITY
13	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-(N-PARA-COUMAROYL)-SEROTONIN-4''-YL]-N-FERULOYL:	INACTIVE
14	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-4''-BIS(N-FERULOYL):	WEAK ACTIVITY
15	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SEROTONIN,4-4''-BIS(N-FERULOYL):	INACTIVE
16	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARCTIIN,2-HYDROXY:	WEAK ACTIVITY
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARCTIIN,2-HYDROXY:	ACTIVE
18	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRACHOROGENIN	WEAK ACTIVITY
19	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TRACHOROGENIN	INACTIVE
20	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MATAIRESINOL GLYCOSIDE	WEAK ACTIVITY
21	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MATAIRESINOL GLYCOSIDE	WEAK ACTIVITY

Gossypium hirsutum (MALVACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	PROTOCATECHUIC ACID	None
2	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	WEAK ACTIVITY
3	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	INACTIVE
4	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
6	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
7	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
8	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	ACTIVE
9	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	INACTIVE
10	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPTHALENE,1-2-3-4-TETRAHYDRO-1-ALPHA-2-BETA-7-TRIHYDROXY-1-BETA-6-DIMETHYL-4-BETA-ISO-PROPYL: 1-O-BETA-D-GLUCOSIDE	WEAK ACTIVITY
11	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPTHALENE,1-2-3-4-TETRAHYDRO-1-ALPHA-2-BETA-7-TRIHYDROXY-1-BETA-6-DIMETHYL-4-BETA-ISO-PROPYL: 1-O-BETA-D-GLUCOSIDE	ACTIVE
12	TYROSINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPTHALENE,1-2-3-4-TETRAHYDRO-1-ALPHA-2-BETA-7-TRIHYDROXY-1-BETA-6-DIMETHYL-4-BETA-ISO-PROPYL: 2-O-BETA-D-GLUCOSIDE	WEAK ACTIVITY
13	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPTHALENE,1-2-3-4-TETRAHYDRO-1-ALPHA-2-BETA-7-TRIHYDROXY-1-BETA-6-DIMETHYL-4-BETA-ISO-PROPYL: 2-O-BETA-D-GLUCOSIDE	ACTIVE